US SB2554 | 2017-2018 | 115th Congress
Status
Completed Legislative Action
Spectrum: Bipartisan Bill
Status: Passed on October 10 2018 - 100% progression
Action: 2018-10-10 - Became Public Law No: 115-263.
Text: Latest bill text (Enrolled) [PDF]
Spectrum: Bipartisan Bill
Status: Passed on October 10 2018 - 100% progression
Action: 2018-10-10 - Became Public Law No: 115-263.
Text: Latest bill text (Enrolled) [PDF]
Summary
Patient Right to Know Drug Prices Act
Title
Patient Right to Know Drug Prices Act
Sponsors
Sen. Susan Collins [R-ME] | Sen. Claire McCaskill [D-MO] | Sen. John Barrasso [R-WY] | Sen. Debbie Stabenow [D-MI] |
Sen. Bill Cassidy [R-LA] | Sen. Tina Smith [D-MN] | Sen. Joe Donnelly [D-IN] | Sen. Dianne Feinstein [D-CA] |
Sen. Lisa Murkowski [R-AK] | Sen. Robert Menendez [D-NJ] | Sen. Tammy Baldwin [D-WI] | Sen. John Kennedy [R-LA] |
Sen. Margaret Hassan [D-NH] | Sen. Richard Blumenthal [D-CT] | Sen. Roger Wicker [R-MS] | Sen. Shelley Capito [R-WV] |
Sen. Heidi Heitkamp [D-ND] | Sen. Deb Fischer [R-NE] | Sen. Lamar Alexander [R-TN] | Sen. John Boozman [R-AR] |
Sen. Angus King [I-ME] | Sen. Sherrod Brown [D-OH] | Sen. Martin Heinrich [D-NM] | Sen. Chuck Grassley [R-IA] |
Sen. Tom Udall [D-NM] | Sen. Amy Klobuchar [D-MN] |
Roll Calls
2018-09-17 - Senate - Amendment SA 4011 S.Amdt.4011 RC# 208 (Y: 11 N: 89 NV: 0 Abs: 0) [FAIL]
2018-09-17 - Senate - Passed Senate with an amendment RC# 209 (Y: 98 N: 2 NV: 0 Abs: 0) [PASS]
2018-09-17 - Senate - Passed Senate with an amendment RC# 209 (Y: 98 N: 2 NV: 0 Abs: 0) [PASS]
History
Date | Chamber | Action |
---|---|---|
2018-10-10 | House | Became Public Law No: 115-263. |
2018-10-10 | House | Signed by President. |
2018-10-01 | House | Presented to President. |
2018-09-25 | House | Motion to reconsider laid on the table Agreed to without objection. |
2018-09-25 | House | On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H8795-8796) |
2018-09-25 | House | DEBATE - The House proceeded with forty minutes of debate on S. 2554. |
2018-09-25 | House | Considered under suspension of the rules. (consideration: CR H8795-8799) |
2018-09-25 | House | Mr. Carter (GA) moved to suspend the rules and pass the bill. |
2018-09-20 | House | Held at the desk. |
2018-09-20 | House | Received in the House. |
2018-09-18 | Senate | Message on Senate action sent to the House. |
2018-09-17 | Senate | Passed Senate with an amendment by Yea-Nay Vote. 98 - 2. Record Vote Number: 209. |
2018-09-17 | Senate | S.Amdt.4011 Amendment SA 4011 not agreed to in Senate by Yea-Nay Vote. 11 - 89. Record Vote Number: 208. |
2018-09-17 | Senate | S.Amdt.4011 Amendment SA 4011 proposed by Senator Alexander for Senator Lee. (consideration: CR S6179; text: CR S6179) To limit application of the gag clause to self-insured group health plans. |
2018-09-17 | Senate | Measure laid before Senate by unanimous consent. (consideration: CR S6179-6180) |
2018-07-31 | Senate | Placed on Senate Legislative Calendar under General Orders. Calendar No. 549. |
2018-07-31 | Senate | Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report. |
2018-07-25 | Senate | Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably. |
2018-03-14 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
SB2553 (Related) 2018-10-10 - Became Public Law No: 115-262.
HB6143 (Same As) 2018-06-19 - Referred to the House Committee on Energy and Commerce.
HB6733 (Related) 2018-09-13 - Ordered to be Reported by Voice Vote.
HB6143 (Same As) 2018-06-19 - Referred to the House Committee on Energy and Commerce.
HB6733 (Related) 2018-09-13 - Ordered to be Reported by Voice Vote.
Subjects
Civil actions and liability
Drug safety, medical device, and laboratory regulation
Health
Health care costs and insurance
Health care coverage and access
Inflation and prices
Prescription drugs
Drug safety, medical device, and laboratory regulation
Health
Health care costs and insurance
Health care coverage and access
Inflation and prices
Prescription drugs